tiprankstipranks
Inogen (INGN)
NASDAQ:INGN

Inogen (INGN) Stock News & Sentiment

341 Followers
Inogen Announces Executive VP and CMO Departure Plans
PremiumCompany Announcements
Inogen Announces Executive VP and CMO Departure Plans
21h ago
Inogen trading resumes
PremiumThe Fly
Inogen trading resumes
2M ago
Inogen trading halted, volatility trading pause
PremiumThe Fly
Inogen trading halted, volatility trading pause
2M ago
Inogen sees Q1 revenue $73M-$74M, one estimate $80.6M
PremiumThe Fly
Inogen sees Q1 revenue $73M-$74M, one estimate $80.6M
2M ago
Inogen reports Q4 EPS ($1.14), consensus (62c)
PremiumThe Fly
Inogen reports Q4 EPS ($1.14), consensus (62c)
2M ago
Is INGN a Buy, Before Earnings?
PremiumPre-Earnings
Is INGN a Buy, Before Earnings?
2M ago
William Blair upgrades Inogen to Outperform on Respironics exit
PremiumThe Fly
William Blair upgrades Inogen to Outperform on Respironics exit
2M ago
More INGN News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is INGN’s Media Buzz Sentiment?
Currently, no data Available
What is INGN’s weekly average amount of articles?
Currently, no data Available
What is INGN’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
SLPSimulations Plus
LGNDLigand Pharma
AVTBFAvant Brands
PHGEBiomX
MNPRMonopar Therapeutics Inc
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis